Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 223-228-4 | CAS number: 3775-90-4
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Acute Toxicity: oral
Administrative data
- Endpoint:
- acute toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- January to March 1990
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: GLP compliant study to OECD guideline with sufficient details on the study and the test substance.
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 1 990
- Report date:
- 1990
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 401 (Acute Oral Toxicity)
- GLP compliance:
- yes
- Test type:
- standard acute method
Test material
- Reference substance name:
- MATBAE
- IUPAC Name:
- MATBAE
- Reference substance name:
- 2-tert-butylaminoethyl methacrylate
- EC Number:
- 223-228-4
- EC Name:
- 2-tert-butylaminoethyl methacrylate
- Cas Number:
- 3775-90-4
- Molecular formula:
- C10H19NO2
- IUPAC Name:
- 2-(tert-butylamino)ethyl 2-methylprop-2-enoate
- Test material form:
- other: liquid
- Details on test material:
- The test substance supplied was MATBAE Norsolor (Orkem group) Service Ecotoxicology, BP No. 22, 60550 Verneuil-en-Halatte, France, under the present as a pale yellow liquid. Test substance packaged in a glass bottle smoke, has been received at CIT 06.02.90 under the reference "MATBAE ref: Lot 1 Stab: 300 ppm HQME" and was preserved at +4 °C (2-tert-butylaminoethyl methacrylate CAS No 3775-90-4 stabilised with 300ppm of the monomethyl ether of Hydroquinone CAS No 150-76-5).
Constituent 1
Constituent 2
Test animals
- Species:
- rat
- Strain:
- Sprague-Dawley
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- Animals
The animals used in this study are Sprague-Dawley strain rats ICO: OFA SD (IOPS Caw) supplied by Iffa Credo (69210 Arbresle. France).
Upon arrival at C. I. T., the animals are acclimated to local conditions for a minimum period of 5 days, during which they are observed daily.
On the first day of treatment, the young adult animals were of an age of approximately 6 weeks and an average weight of 186 ± 6 g for males and 148 ± 6 g for females. They are individually identified by holes or slots in their ears.
Environment
During the period of acclimation and during the study, the animals were kept in a conventional airconditioned animal room.
Conditions were maintained at:
Temperature 22 ± 3 ° C
Humidity 50 ± 20% relative humidity
Light cycle 12 hours of light/12 hours of darkness
The non-recycled air, was filtered through absolute filters
.
The animals are housed with 4 to 7 animals of the same sex during the acclimation period and 5 of the same sex during the study. Animals are housed in a sterilisable polycarbonate cage (dimensions 48 x 27 x 20 cm) equipped with a stainless steel lid forming a food hopper and a
water bottle (500 ml).
Animals were housed on sifted saw dust (Societe Parisienne of Sawdust, 95100 Argenteuil, France). The analysis for potential residues and major contaminants is performed
regularly (Municipal and Regional Laboratory of Rouen, 76000 Rouen,
France).
The animals were fed with Rat and Mice diet A04 Reference C "(UAR 91360 Villemoisson-sur-Orge, France) presented as standardized pellets, provided ad libitum throughout the
duration of the study (except for the period of fasting prior to treatment). The analysis of the food and the result for the main contaminants (pesticides, heavy metals, mycotoxins, etc ...)
are given by the supplier with each batch.
Drinking water was filtered with a 0.22 micron membrane (Millipore Corporation, 78140 Velizy, France) was provided ad libitum during the study. It was dispensed in bottles. Bacteriological and chemical analyzes and the main contaminants are performed regularly
(Municipal and Regional Laboratory of Rouen, 76000 Rouen, France).
There was no information available to the Study Director 1 indicating the presence in food or drinking water for any contaminants a level sufficient to adversely affect the conduct of the study.
Administration / exposure
- Route of administration:
- oral: gavage
- Vehicle:
- other: None or 0.5% methyl cellulose in water
- Details on oral exposure:
- Before the day of treatment, the animals are fasted only provided with water for about 18 hours before administration. The food was returned 4 hours after treatment.
In a first test, the test substance was administered undiluted to a group of 10 animals (5 males and 5 females) at a dose of 2000 mg / kg in a volume taking into account the density of the test substance d = 0.92.
Mortality being greater than 50%, a preliminary study was performed with a reduced number of animals to find approximately the scale of doses administered for the determination of the LD 50.
The next phase of the study included four groups of five males and two groups of five females.
The dose levels for the males being 500, 800, 1300 and 2000mg/kg at a dose volume of 10mg/kg of the suspension. For the female just 800 and 1300mg/kg were administered.
Administration of the test substance
The doing suspensions were administered using an 18G stainless steel 2 inch gavage. - Doses:
- In a first test, the test substance was administered undiluted to a group of 10 animals (5 males and 5 females) at a dose of 2000 mg / kg in a volume taking into account the density of the test substance d = 0.92.
For the second phase of the experiment the dose levels for the males were 500, 800, 1300 and 2000mg/kg at a dose volume of 10mg/kg of the suspension. For the female just 800 and 1300mg/kg were administered - No. of animals per sex per dose:
- In a first test, the test substance was administered undiluted to a group of 10 animals (5 males and 5 females).
The second test included four groups of five males and two groups of five females. - Control animals:
- no
- Details on study design:
- TREATMENT
Before the day of treatment, the animals are fasted only provided with water for about 18 hours before administration. The food was returned 4 hours after treatment.
In a first test, the test substance was administered undiluted to a group of 10 animals (5 males and 5 females) at a dose of 2000 mg / kg in a volume taking into account the density of the test substance d = 0.92.
Mortality being greater than 50%, a preliminary study was performed with a reduced number of animals to find approximately the scale of doses administered for the determination of the LD 50.
The next phase of the study included four groups of five males and two groups of five females.
The dose levels for the males being 500, 800, 1300 and 2000mg/kg at a dose volume of 10mg/kg of the suspension. For the female just 800 and 1300mg/kg were administered.
Administration of the test substance
The doing suspensions were administered using an 18G stainless steel 2 inch gavage.
Clinical Investigations
The animals were observed frequently during the hours after administration of the test substance. It was then performed at least once daily for 14 days to record if the clinical signs
reversible or irreversible.
Mortality
Checking for deaths was done frequently performed during the hours after administration of the test substance and at least 2 times a day for the 14 days of observation. The time of death was noted individually in days or hours from the time of administration of the test substance.
Body weights
The animals were weighed individually just before the administration of test substance, then on days 5, 8 and 5. The changes in the animals bodyweights were compared with a reference curve established at CIT from untreated animals with the same initial weight.
Pathology
Dead animals in the test were given a post mortem examination. Then on the15th day, the surviving animals were sacrificed by inhalation of an excess of C02 and examined post mortem. After opening the abdominal and thoracic cavities, a macroscopic examination of the major organs is carried out: the digestive tract, heart, kidneys, liver, lungs, pancreas, spleen and other organs with abnormalities. Organs presenting macroscopic lesions were preserved in an appropriate fixative (10% formalin). No histological examination was performed. - Statistics:
- None
Results and discussion
Effect levels
- Sex:
- male/female
- Dose descriptor:
- LD50
- Effect level:
- > 800 - < 2 000 mg/kg bw
- Based on:
- test mat.
- Remarks on result:
- other: no statistical analysis
- Mortality:
- There were no mortalities at 500 mg/kg in males and 800 mg/kg in both males and females. When dose at 2000 mg/kg (undiluted) 4 out of five males and all five females died. Mortalities in the males at 2000 mg/kg using the suspension in 0.5% methyl cellulose were three of the five rats.
Details are provided in the table below. - Clinical signs:
- other: The following clinical signs were observed after the administration of test substance: Hypokinesia was seen at 500 mg / kg and 800 mg / kg Hypokinesia and sedation with an associated piloerection were seen after 4 hours and dyspnea on day 3 at a dose
- Gross pathology:
- The post mortem examination of animals found dead on day 1 (doses of 1300 and 2000 mg / kg)
found the presence of an abnormally reddish coloration to the stomach and intestines. In animals found dead on day 5 there were no detectable abnormality.
The autopsy of animals sacrificed at the end of study did not find any abnormalities
Any other information on results incl. tables
Mortality by sex separately or combined is presented below:
|
|
|
Cumulative |
Mortality |
|
|
|
Sex |
Dose mg/kg |
Volume ml/kg |
Day 1 |
Day 2 |
Day5 |
Day 15 |
% mortality |
Males |
500 |
10 |
0 |
0 |
0 |
0 |
0 |
|
800 |
10 |
0 |
0 |
0 |
0 |
0 |
|
1300 |
10 |
1 |
1 |
1 |
1 |
20 |
|
2000 |
10 |
2 |
2 |
3 |
3 |
60 |
|
2000 |
2.18 |
4 |
4 |
4 |
4 |
80 |
|
|
|
|
|
|
|
|
Females |
800 |
10 |
0 |
0 |
0 |
0 |
0 |
|
1300 |
10 |
0 |
0 |
0 |
0 |
0 |
|
2000 |
2.18 |
5 |
5 |
5 |
5 |
100 |
|
|
|
|
|
|
|
|
Males & |
800 |
10 |
0 |
0 |
0 |
0 |
0 |
Females |
1300 |
10 |
1 |
1 |
1 |
1 |
10 |
combined |
2000 |
2.18 |
9 |
9 |
9 |
9 |
90 |
Applicant's summary and conclusion
- Interpretation of results:
- Toxicity Category IV
- Remarks:
- Migrated information Criteria used for interpretation of results: EU
- Conclusions:
- Under the conditions of this experiment the LD 50 of the MATBAE administered orally in rats was higher than 800 mg / kg (0% death) and lower than 2000 mg / kg (60% death). The toxicity of the test substance in females is comparable to that of males.
This results in a classification of Category 4 for acute oral toxicity by the EU CLP(GHS) criteria. - Executive summary:
The acute toxicity of MATBAE was assessed in rats in accordance with the Guideline No. 401 (OECD - February 24, 1987) for oral acute toxicty and according to the rules of Good Laboratory Practice (O.C.D.E. - May 12, 1981).
Materials and Methods
In a first test, the test substance was administered orally as is to a group of 10 Sprague-Dawley rats (5 males and 5 females) at a dose of 2000 mg / kg in a volume taking into account the density of the test substance = 0.92.
In a second experiment, the test substance was administered at doses of 500, 800, 1300 and 2000 mg / kg to 4 groups of 5 males and at doses of 800 and 1300 mg / kg to groups of 5 females. The test substances suspended in 0.5% methylcellulose and was administered in volume of 10 ml / kg.
All animals were starved over night before treatment. Mortality, the general behavior and the general condition and the weight gain in the surviving animals were followed for a period of 14 days after the administration one of the Test substance. A pathological examination was performed on each animal find dead or sacrificed at the end of study.
Results
After administration of the test substance as the mortality is 90% at the 2000 mg / kg. After administration of the test substance in suspension, mortality in males, were respectively 0%, 0%, 20% and 60% to Doses of 500, 800, 1300 and 2000 mg / kg and is in females of 0%, 0% at doses of 800 and 1300 mg / kg. The death of animals is essentially recorded between 1 hour and 4 hours after treatment.
The observed clinical signs include a decrease in spontaneous activity for 24 hours at a dose of 500 mg / kg for 48 hours with the 800 mg / kg dose, for 6 days at doses of 1300 and 2000 mg / kg. Symptoms of difficulty breathing and piloerection were occasionally observed at doses of 1300 and 2000 mg / kgThebody weight gainof surviving animals was normal at doses of 500and 800mg/kgthroughout the durationof the study. A slight reduction in weight gain at1300mg /kg and more significantly at2000mg /kg was observed between days 1 and5. with subsequent normal bodyweight recovery on days 8 to 15.
The autopsy of dead animals found dead on day 1(dosesof 1300and 2000mg /kg) showed the presence of an abnormally reddish coloration levelof the stomach and intestines. In animals found dead on day 5 (dose2000 mg / kg of the test substance suspended) noabnormalities were detectable.The autopsy in all animals sacrificed at the end ofthe study showed macroscopically visible abnormalities.
Conclusion
Under the conditions of this experiment the LD 50 of the MATBAE administered orally in rats was higher than 800mg /kg (0%death) and lower than 2000mg /kg (60%death).The toxicity of the test substance in females is comparable to that of males.This results in a classification of Category 4 for acute oral toxicity by the EU CLP(GHS) criteria.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.